Author

Changrui Jiang

Institutions: China Medical University, China Medical University

Observed institutions: National Natural Science Foundation of China, China Medical University, First Hospital of China Medical University, China Medical University

ORCID: 0000-0001-9880-7037

Observed ORCID: 0000-0001-9880-7037

OpenAlex ID: A5007591939

SPOCK2 and SPRED1 function downstream of EZH2 to impede the malignant progression of lung adenocarcinoma in vitro and in vivo

2023 · Yang Liu, Xiaoxi Fan, et al. · Human Cell · 11

A cyclin D1-positive diffuse large B-cell lymphoma of germinal center B-cell-like subtype in the right tonsil

2017 · Changrui Jiang, Xiuying Shi, et al. · Medicine · 2

HOXD11 promotes lung adenocarcinoma progression by transcriptionally activating CREB5 and enhancing AKT/mTOR signaling

2026 · Jiahong Han, Changrui Jiang, et al. · Research Square

Abstract 5394: Detecting pulmonary malignancy against benign nodules using non-invasive cfDNA fragmentomics assay

2023 · Shun Xu, Ji Luo, et al. · Cancer Research

Construction and Evaluation of a Preoperative Prediction Model for Lymph Node Metastasis of cIA Lung Adenocarcinoma Using Random Forest

2022 · Chuhan Zhang, Shun Xu, et al. · Journal of Oncology

Works count: 5

Citation count: 13

H-index: 2

I10-index: 1